Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice-Reference-Cited by-同舟云学术

Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice

Published:2005-03 Issue:3 Volume:61 Page:908-914
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zips Daniel,Hessel Franziska,Krause Mechthild,Schiefer Yvonne,Hoinkis Cordelia,Thames Howard D.,Haberey Martin,Baumann Michael

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference45 articles.

1. Angiogenesis in cancer, vascular, rheumatoid and other disease;Folkman;Nat Med,1995

2. Tumorigenesis and the angiogenic switch;Bergers;Nat Rev Cancer,2003

3. Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy;Dvorak;J Clin Oncol,2002

4. The biology of VEGF and its receptors;Ferrara;Nat Med,2003

5. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors;Schlaeppi;Cancer Metastasis Rev,1999

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to deal with the relationship between hypoxia and radiotherapy in the hypofractionated radiotherapy era?;INT J RADIAT RES;2021

2. Hypoxia and its Modification in Bladder Cancer: Current and Future Perspectives;Clinical Oncology;2021-06

3. Value of functional in-vivo endpoints in preclinical radiation research;Radiotherapy and Oncology;2021-05

4. Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial;Radiotherapy and Oncology;2021-02

5. Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy;Cancer Research;2019-08-19